Publisher Correction to: Adenosine receptor signalling in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-9546
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Publisher Correction to: Adenosine receptor signalling in Alzheimer’s disease ; volume:18 ; number:4 ; day:16 ; month:11 ; year:2022 ; pages:407 ; date:12.2022
Purinergic signalling ; 18, Heft 4 (16.11.2022), 407, 12.2022
- Urheber
-
Trinh, Phuc N. H.
Baltos, Jo-Anne
Hellyer, Shane D.
May, Lauren T.
Gregory, Karen J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11302-022-09906-x
- URN
-
urn:nbn:de:101:1-2023032020592367241508
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Trinh, Phuc N. H.
- Baltos, Jo-Anne
- Hellyer, Shane D.
- May, Lauren T.
- Gregory, Karen J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adenosine receptor signalling in Alzheimer’s disease
Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective
Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
Retraction of “Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling”
RIG-1 receptor expression in the pathology of Alzheimer’s disease
Alzheimer’s Disease
Publisher Correction: Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease
Publisher Correction: Pattern of Altered Plasma Elemental Phosphorus, Calcium, Zinc, and Iron in Alzheimer’s Disease
Role of transient receptor potential ankyrin 1 channels in Alzheimer’s disease
N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer’s disease
Adenosine receptor signalling in Alzheimer’s disease
Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective
Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
Retraction of “Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling”
RIG-1 receptor expression in the pathology of Alzheimer’s disease
Alzheimer’s Disease
Publisher Correction: Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease
Publisher Correction: Pattern of Altered Plasma Elemental Phosphorus, Calcium, Zinc, and Iron in Alzheimer’s Disease
Role of transient receptor potential ankyrin 1 channels in Alzheimer’s disease
N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer’s disease
Adenosine receptor signalling in Alzheimer’s disease
Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective
Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
Retraction of “Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling”
RIG-1 receptor expression in the pathology of Alzheimer’s disease
Alzheimer’s Disease
Publisher Correction: Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease
Publisher Correction: Pattern of Altered Plasma Elemental Phosphorus, Calcium, Zinc, and Iron in Alzheimer’s Disease
Role of transient receptor potential ankyrin 1 channels in Alzheimer’s disease